While major technology peers from Microsoft to Amazon have recently regained their footing, Oracle shares continue their precipitous decline. The catalyst for the sell-off is a colossal, $300 billion cloud computing agreement with OpenAI—a deal that has generated investor anxiety rather than euphoria. Since peaking above $340 in September, the stock has shed approximately 40% of its value. The central question for the market is whether Oracle can validate its strategy or if this aggressive artificial intelligence push will turn into a costly misadventure.
Wall Street’s Divided Verdict
Analyst sentiment presents a fractured landscape. Deutsche Bank and HSBC maintain buy ratings, with price targets of $375 and $382 respectively. Their optimism hinges on Oracle’s massive backlog of over $500 billion in committed future contracts.
However, a growing chorus of skepticism is emerging. DA Davidson slashed its target dramatically from $300 to $200, expressing doubts about the substance of the OpenAI bookings. An even more bearish view comes from Rothschild & Co Redburn, which issued a sell recommendation with a $175 price target, arguing the market is grossly overvaluing the cloud contracts. On average, the consensus among 39 analysts sits at $342, implying significant upside potential—but only if Oracle executes flawlessly.
The Stunning November Sell-Off
The downturn turned severe in November, with the equity plunging 23.1% in that month alone. This collapse completely erased all gains achieved after a strong quarterly report in September. That report had initially sparked enthusiasm by revealing a quadrupled remaining performance obligation (RPO) of $455 billion.
Currently, the stock is battling to hold the $200 level. Brief recovery attempts toward $210 have failed, with sellers maintaining control. This weakness persists even as broader technology sector sentiment shows signs of improvement.
Anatomy of Investor Anxiety
Several key factors are driving the negative momentum:
A Ballooning Debt Load: Oracle has already issued $18 billion in new bonds and is reportedly negotiating an additional $38 billion in financing with Vantage Data Centers. The sheer scale of this potential debt raises questions about the company’s ability to manage the financial burden.
Should investors sell immediately? Or is it worth buying Oracle?
The OpenAI Uncertainty: The mega-deal with the creator of ChatGPT sounds impressive on paper, but OpenAI’s ability to fulfill its substantial payment commitments is under scrutiny. Doubts about the AI firm’s financial durability are weighing heavily on Oracle’s valuation.
Insider Selling Activity: A noticeable increase in stock sales by corporate insiders has coincided with the share price decline. This trend is often interpreted as a lack of confidence from those with the closest view of the business.
Technical Breakdown: From a chart perspective, the stock has broken through crucial support levels and now trades below key moving averages. The $190 zone is viewed as critical; a sustained breach could trigger further declines toward the $120-$140 range.
Unprecedented Capital Expenditure for Cloud Growth
Oracle’s strategic pivot demands investment on an extraordinary scale. The company plans to pour $35 billion into expanding its cloud infrastructure in the current fiscal year 2026, a massive increase from $21.2 billion the prior year. This spending surge aims to more than double its data center count from 37 to 71.
Management forecasts cloud revenue will jump 77% to $18 billion this year, with a long-term target of $144 billion by 2030. While executives emphasize that most investments are directed toward revenue-generating hardware, the magnitude of the spending is unnerving shareholders. The risk of operational missteps or slower-than-expected returns is considerable.
The Upcoming Earnings Report: A Crucial Test
All eyes are on December 8, when Oracle is scheduled to release results for the second quarter of fiscal 2026. This report will be scrutinized for concrete updates on the OpenAI partnership, current cloud revenue growth, and, most importantly, confirmation of the company’s ambitious multi-year forecasts.
With a price-to-earnings ratio hovering near 30, Oracle’s valuation appears fair by historical standards. However, the elevated debt profile and uncertainties surrounding the AI infrastructure expansion have fundamentally altered the investment risk profile. For now, a significant portion of the market is choosing to avoid the gamble.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from December 3 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.
Oracle: Buy or sell? Read more here...
